OBJECTIVE To prepare ofloxacin liposomes for increasing bacteria sensitivity, and to evaluate its in vitro property. METHODS Ofloxacin liposomes were prepared by pH gradient method using phospholipid and cholesterol as materials. The effects of pH value and the warming temperature and time on encapsulation efficiency were investigated. The particle size of liposomes was determined and the morphology was investigated by transmission electric microscope (TEM). The in vitro release experiment was carried out using physiological saline as the medium. The bacteriostatic action against Staphylococcus aureus was investigated using disc diffusion test and dilution test. RESULTS The maximum encapsulation efficiency of 82.40% could be achieved when pH value was 7.0, warming temperature was 50 ℃ and warming time was 5 min. The average particle size of the liposomes was 174 nm, and the ofloxacin liposomes showed good morphology under TEM. The liposomes could release ofloxacin in a sustained manner in vitro. The ofloxacin liposomes and solution showed same inhibition zones in disc diffusion test, while their minimal inhibitory concentrations determined by dilution test were 0.39 and 0.78 μg·mL-1, respectively. CONCLUSION Ofloxacin liposomes can be prepared by pH gradient method with high encapsulation efficiency, and the bacteriostatic effect of ofloxacin against Staphylococcus aureus can be improved by incorporating it into liposomes.
HAN Gang, YU Zhen-wei, MA Ke*.
Preparation and in Vitro Evaluation of Ofloxacin Liposomes for Increasing Bacteria Sensitivity[J]. Chinese Pharmaceutical Journal, 2013, 48(8): 612-614 https://doi.org/10.11669/cpj.2013.08.009
GOLD H S,MOELLERING R C. Antimicrobial drug resistance. N Engl J Med,1996,335(19):1445-1453. WALSH C. Molecular mechanisms that confer antibacterial drug resistance. Nature,2000,406(6797):775-781. HUH A J,KWON Y J. "Nanoantibiotics":A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Controlled Release,2011,156(2):128-145. ALIPOUR M,HALWANI M,OMRI A, et al. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm,2008,355(1-2):293-298. TUROS E,SHIM J Y,WANG Y, et al. Antibiotic-conjugated polyacrylate nanoparticlesNew opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett,2007,17(1):53-56. DRULIS-KAWA Z,DOROTKIEWICZ-JACH A. Liposomes as delivery systems for antibiotics. Int J Pharm,2010,387(1-2):187-198. SUN Q J,LIANG X,ZHENG Q, et al. Resistance of helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World J Gastroenterol, 2010,16(40):5118-5121. ZHANG Q,ZHU J B,QIU L M. Study on encapsulation efficiency and in vitro release profile of levofloxacin hydrochloride liposome . J China Pharm Univ(中国药科大学学报),2004, 35(6):508-512. HALWANI M,BLOMME S,SUNTRES Z E, et al. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin. Int J Pharm,2008,358(1-2):278-284.